Omega-3 fatty acids (fish oil) & Alzheimer disease

Written based on 30 research studies on PubMed, searched on 11 Nov 2026.

The claim

Posts online say that omega-3 fatty acids (fish oil) helps with Alzheimer disease.

Where research stands

We found 252 published papers on omega-3 fatty acids (fish oil) and Alzheimer disease. They were published between 1990 and 2026. 30 of them are studies in people. 28 of them compared people who got it with a group that did not. 73 were studies in animals, and 14 were only in cells in the lab. 88 papers are reviews that sum up other studies. 2 research projects on omega-3 fatty acids (fish oil) for Alzheimer disease are funded and still running.

• 30In people28 with a comparison group
• 73In animals
• 14Only in the lab

What the studies found

We have not summed up these studies in words yet. The most important papers are listed under Sources.

Verdict

Sources

1. Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial.2023 · Alzheimers Res Ther · Randomised trial
2. Dietary fish oil increases catalase activity in patients with probable Alzheimer's disease.2022 · Nutr Hosp · Randomised trial
3. Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease.2022 · J Alzheimers Dis · Randomised trial
4. Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial.2022 · Brain Behav Immun · Randomised trial
5. Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study.2021 · J Alzheimers Dis · Randomised trial
6. Effect of long-term omega-3 supplementation and a lifestyle multidomain intervention on intrinsic capacity among community-dwelling older adults: Secondary analysis of a randomized, placebo-controlled trial (MAPT study).2020 · Maturitas · Randomised trial
7. Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial.2020 · EBioMedicine · Randomised trial
8. Cortical β-Amyloid in Older Adults Is Associated with Multidomain Interventions with and without Omega 3 Polyunsaturated Fatty Acid Supplementation.2020 · J Prev Alzheimers Dis · Randomised trial
9. Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial.2020 · J Alzheimers Dis · Study in people
10. Effect of Long-Term Omega 3 Polyunsaturated Fatty Acid Supplementation with or without Multidomain Lifestyle Intervention on Muscle Strength in Older Adults: Secondary Analysis of the Multidomain Alzheimer Preventive Trial (MAPT).2019 · Nutrients · Study in people
11. Structural and metabolic reprogramming by docosahexaenoic acid in neuronal cell models of Alzheimer's disease.2026 · Biochimie · Review
12. Omega-3 Fatty Acids and Alzheimer's Disease: Toward a New Understanding of Neuroprotective Mechanisms and Intervention Strategies.2026 · Mar Drugs · Review
13. Neuroinflammation in Alzheimer's Disease: The Role of Obesity, Gut Microbiota, and Therapeutic Potential of Omega-3 Fatty Acids and Neural Stem Cells.2026 · J Nutr · Review
14. Effect of Omega-3 Polyunsaturated Fatty Acid Supplements on Cognitive Performance in Patients with Mild Cognitive Impairment or Alzheimer's Disease: A Systematic Review and Meta-Analysis.2025 · Nutr Rev · Review
15. Omega-3 polyunsaturated fatty acids in neurodegenerative disorders: Mixed designs = mixed results.2025 · Prog Lipid Res · Review
16. Neuroprotective Role of Omega-3 Fatty Acids: Fighting Alzheimer's Disease.2025 · Molecules · Review
17. Docosahexaenoic acid remodels lipid composition of lipid rafts and mitochondrial function in ApoE4/4 mouse brain: a multi-omic investigation.2026 · Mol Biomed · In animals
18. Docosahexaenoic acid improves cognitive function and reduces neuronal apoptosis in an Alzheimer's disease mouse model: association with reduced oxidative stress and telomere attrition.2026 · Nutr Neurosci · In animals
19. Oleic and omega-3 fatty acids buffer neuroinflammation in a scopolamine model with Alzheimer's-like features via target-level interactions.2026 · Food Funct · In animals
20. Effects of UMP, Choline, and Fish Oil on Synaptic Integrity and Motor Coordination in an Alzheimer's Disease Mouse Model.2026 · Int J Mol Sci · In animals
21. Supplementation with fish oil reduces αβ 42 burden and shifts αβ precursor protein processing toward non-amyloidogenic pathways in a rat model of hyperglycaemic Alzheimer's disease.2025 · J Nutr Sci · In animals
22. Dual Mechanism of Docosahexaenoic acid (DHA) in Alzheimer's Disease: PAD4 Inhibition and Autophagy Stimulation.2025 · Mol Neurobiol · In animals
23. Docosahexaenoic acid modulates microglial autophagy via miR-589-5p/toll-like receptor 4 axis in Alzheimer's disease.2026 · Neuroreport · In the lab
24. Increasing the Survival of a Neuronal Model of Alzheimer's Disease Using Docosahexaenoic Acid, Restoring Endolysosomal Functioning by Modifying the Interactions between the Membrane Proteins C99 and Rab5.2024 · Int J Mol Sci · In the lab
25. Understanding the cholesterol metabolism-perturbing effects of docosahexaenoic acid by gas chromatography-mass spectrometry targeted metabonomic profiling.2017 · Eur J Nutr · In the lab
26. Oxidized Docosahexaenoic Acid Species and Lipid Peroxidation Products Increase Amyloidogenic Amyloid Precursor Protein Processing.2016 · Neurodegener Dis · In the lab
27. Omega-3 fatty acids and Alzheimer's disease-related brain biomarkers in older adults enriched for preclinical Alzheimer's disease.2026 · Prostaglandins Leukot Essent Fatty Acids · Other paper
28. The association between omega-3 supplementation and cognitive decline in older adults.2026 · J Prev Alzheimers Dis · Other paper
29. Higher Total Omega-3 PUFA Levels and a Lower Omega-6:Omega-3 Ratio Are Associated with Lower Temporal Lobe Volume in Alzheimer's Disease.2026 · Mol Neurobiol · Other paper
30. Serum long-chain omega-3 and omega-6 fatty acids differentially predict brain atrophy, white matter hyperintensities, and lacunes in individuals with cerebral small vessel disease with or without Alzheimer's disease.2026 · J Alzheimers Dis · Other paper